title: Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma without Castleman's disease; treatment with rituximab.
authors.forename: Martijn
authors.initials: M
authors.lastname: Meijs
authors.forename: Jan
authors.initials: J
authors.lastname: Mekkes
authors.forename: Carel
authors.initials: C
authors.lastname: van Noesel
authors.forename: Erik
authors.initials: E
authors.lastname: Nijhuis
authors.forename: Onno
authors.initials: O
authors.lastname: Leeksma
authors.forename: Marcel
authors.initials: M
authors.lastname: Jonkman
authors.forename: Rick
authors.initials: R
authors.lastname: Hoekzema
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies / Q000032:analysis; D054740:Dendritic Cell Sarcoma, Follicular / Q000150:complications*; D017809:Fatal Outcome; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007155:Immunologic Factors / Q000627:therapeutic use; D007159:Immunologic Tests; D008297:Male; D008875:Middle Aged; D009092:Mucous Membrane / Q000473:pathology; D010257:Paraneoplastic Syndromes / Q000175:diagnosis* / Q000628:therapy; D010392:Pemphigus / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D010956:Plasmapheresis; D000069283:Rituximab; D012867:Skin / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D007074:Immunoglobulin G; D007155:Immunologic Factors; D000069283:Rituximab